Utilization of LppX protein from Mycobacterium tuberculosis for development of recombinant tuberculosis vaccine
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Tuberculosis (TB) is a contagious disease caused by the bacterium Mycobacterium tuberculosis (MTB). Today, BCG is the only vaccine used against TB. However, the protection of this vaccine in adults is insufficient. The purpose of this study was to clone the lppX gene from MTB isolate and to purify recombinant LppX protein for development of recombinant TB vaccine. The lppX gene from MTB strain, isolated from a TB patient in our country, was cloned into first pGEM-T and then pET28a vectors and transferred to E. coli BL21 strain. His-tag recombinant LppX protein expressed in E. coli was purified using nickel columns, and a 7: 3 vaccine formulation was prepared with Montanide ISA 720 VG adjuvant. Vaccine formulation, adjuvant and BCG vaccine, weres. c injected to 5 Balb/c miceand serum samples were collected at regular intervals from mice. The Western blot assay was performed to qualitatively screen the recombinant protein. While bands of the expected size were observed using the recombinant protein and the BCG vaccine-specific serum, the band was not observed only when the adjuvant-specific serum was used. When the IgG values were compared before and after immunization, the vaccine formulationwas significantly increased the humoral immune response. The capacity of these formulations to induce cellular immunity in Balb/c mice was measured by serum interferon-gamma (IFN-γ) and interleukin-12 (IL-12) levels. It was observed that the LppX formulation was as effective as the BCG vaccine in increasing the level of IFN-γ but it was not sufficient to boost IL-12 levels. In future studies, it is thought that double or triple fusions to be formed with different immunogenic proteins may be more effective.
Author
Cennet Doğan
How to Cite
Cennet Doğan (Master Thesis). Utilization of LppX protein from Mycobacterium tuberculosis for development of recombinant tuberculosis vaccine, 2019, Çankırı Karatekin Üniversitesi.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Çankırı Karatekin Üniversitesi
- Transcription and evaluation of the Çerkeş District Population Register dated 1844 (H.1259)(2023)
- Irak'in Al-Diwaniyah şehrinde akut miyokard enfarktüsü için trombolitik tedavi gören hastaların hemşirelik yönetimine ilişkin hemşirelerin bilgilerinin değerlendirilmesi(2023)
- The role of conservatism in women's participation in Türkiye's working life(2023)
- The effect of social media and lifestyle migration on young people's migration motivations(2024)
- Molecular study of virulence factors and bioformatic of Staphylococcus aureus isolated from pregnant women suffering from urinary tract infection in Iraqi population(2022)
- 3 numaralı Çankırı Şer'iyye Sicilinin (H.1091-1092/M.1680-1681) transkripsiyon ve değerlendirmesi(2019)
